REGN R&D Expenses

Regeneron Pharmaceuticals · R&D Expenses

REGN logo

REGN R&D Expenses

Latest reported$6.46B
REGN TTM R&D Expenses ($0.00 → $6.46B)
High-resolution chart · PNG

REGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
6,461,200,000
6,261,300,000
5,955,600,000
5,755,400,000
5,525,000,000
5,317,200,000
5,233,000,000
4,857,699,999
4,499,899,999
4,258,199,999
4,004,399,999
3,895,400,000
3,744,200,000
3,481,900,000
3,249,700,000
3,019,200,000
2,792,700,000
2,715,900,000
2,621,900,000
2,593,600,000
2,626,700,000
2,646,800,000
2,499,099,999
2,499,399,999
2,347,199,999
2,517,399,999
2,424,700,000
2,300,041,000
2,348,471,999
2,010,718,999
2,037,846,999
1,972,881,999
1,943,381,000
1,922,583,000
1,929,675,000
1,886,505,000
1,909,682,999
1,994,763,999
1,995,555,999
2,006,459,999
1,917,176,000
1,747,576,000
1,620,577,000
1,511,112,000
1,422,916,000
1,327,087,000
1,271,353,000
1,187,748,000
1,074,065,000
967,027,000
859,947,000
772,831,000
707,081,000
666,991,000
625,554,000
573,571,000
543,200,000
538,976,000
529,506,000
525,677,000
519,796,000
501,173,000
489,252,000
482,830,000
466,221,000
435,926,000
400,601,000
358,125,000
326,546,000
298,892,000
278,016,000
266,527,000
244,361,000
221,648,000
201,613,000
172,562,000
155,681,000
146,215,000
137,064,000
139,201,000
145,509,000
151,753,000
155,581,000
152,459,000
144,171,000
139,826,000
136,095,000
134,573,000
136,395,000
133,815,000
136,024,000
137,212,000
136,856,000
133,841,000
124,926,000
120,571,000
111,316,000
100,210,000
91,540,000
77,226,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.